adplus-dvertising
Connect with us

Science

Watch SpaceX launch a U.S. spy satellite live and bring its booster back for a landing on terra firma – Yahoo Movies Canada

Published

 on


GlobeNewswire

Dr. Regina Rabinovich Succeeds Dr. Axel Hoos as Sabin Vaccine Institute Board Chair, Drs. Norman Baylor and JoAnn Suzich Join the Board

Washington DC, Dec. 17, 2020 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute (Sabin) is pleased to announce the Board of Trustees has unanimously elected Regina Rabinovich, MD, MPH, as board chair and elected two new trustees, Dr. Norman Baylor and Dr. JoAnn Suzich, to strengthen the organization’s leadership in global immunization and vaccine research and development. Dr. Rabinovich has served on the board since November 2015, and as chair of the Governance Committee since 2016.Dr. Rabinovich brings deep global health expertise to the role, with more than three decades of experience in the health and philanthropic sectors. She is currently the ExxonMobil Malaria Scholar in Residence at the Harvard T.H. Chan School of Public Health. In addition, Dr. Rabinovich is chair of the Malaria Eradication Scientific Alliance at ISGlobal, University of Barcelona, where she also serves as director of the Malaria Elimination Initiative.Previously, Dr. Rabinovich spent nearly a decade as director of the infectious diseases division at the Bill & Melinda Gates Foundation, overseeing the product development and implementation of strategies to prevent and control infectious diseases. She also held senior positions at the U.S. National Institute of Allergy and Infectious Diseases and served as director of the PATH Malaria Vaccine Initiative.Dr. Rabinovich takes on the role of board chair from Axel Hoos, MD, who has been a member of the board since 2006 and has served as chair since January 2014.In his six years as board chair, Dr. Hoos led Sabin through a significant and successful transition, with recruitment of new executive leadership, and development and execution of a new strategy that has resulted in the growth of Sabin’s team, funding and programs, including the successful relaunch of Sabin’s vaccine research and development program. Dr. Hoos is senior vice president, R&D governance chair and therapeutic area head for Oncology at GlaxoSmithKline (GSK). Dr. Hoos continues to serve on the board as a trustee, re-elected alongside Wendy Commins Holman, CEO and founder of Ridgeback Biotherapeutics, who joined the board in 2017.“I am honored to have served Sabin as chair during a time of great change and growth,” said Dr. Hoos. “I am proud of what Sabin has achieved during my tenure and am confident in the future of the organization under Gina’s capable leadership.”“I speak for the entire board in thanking Axel for his vision and dedication to Sabin,” said Dr. Rabinovich. “His leadership has been invaluable in establishing a firm foundation to build upon as we move forward into the organization’s next phase. As desperately needed COVID-19 vaccines become a reality, the Sabin team looks forward to taking an active role in ensuring equity in the global rollout of these vaccines and continuing our work to prevent future pandemics.”Joining the board as trustees are vaccine research and development veterans Norman Baylor, PhD, and JoAnn Suzich, PhD, whose expertise will strengthen Sabin as a non-profit organization developing vaccines against diseases that impact populations in low- and middle-income settings.   Dr. Norman Baylor is President and CEO of Biologics Consulting Group, Inc. Prior to this, he spent more than 20 years at the U.S. Food and Drug Administration (FDA), most recently as Director of the Office of Vaccines Research and Review in the Center for Biologics Evaluation and Research. Dr. Baylor’s expertise in the development and licensure of new vaccines will be valuable to Sabin as the organization’s vaccine research and development program advances novel vaccines into clinical trials.“I am honored to join the Sabin board to help advance the vaccines currently being developed and identify new vaccine development opportunities,” said Dr. Baylor. “The present moment has made it abundantly clear how vital vaccines are for our global health, and I am glad to have the opportunity to contribute to research-based interventions as a part of the Sabin team.”Dr. JoAnn Suzich brings more than 30 years of experience in infectious diseases and vaccine research to Sabin, with a focus on translating science into global solutions for patient care. Dr. Suzich currently serves as head of research at Immunocore after an impressive career at AstraZeneca/MedImmune, where she started her career as a scientist and was elevated to vice president and then therapeutic head before retiring last year. “As a patient-focused scientist, I am excited to join an organization that works on behalf of people in low-income settings worldwide, including close collaboration with Sabin’s vaccine development team. I look forward to helping Sabin realize its mission of making vaccines accessible to everyone, everywhere,” Suzich commented.Baylor and Suzich join Hoos and Rabinovich, CEO Amy Finan, Elizabeth Fox, Wendy Commins Holman, Jeffrey P. Libson, Saad Omer, David Salisbury, Jaqueline Shea and Peter L. Thoren as Sabin Board Trustees. Learn more at www.sabin.org/board-trustees.  About the Sabin Vaccine Institute The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non-profit with more than two decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit www.sabin.org and follow us on Twitter, @SabinVaccine. About Norman Baylor, PhDDr. Norman W. Baylor is an expert in the development and licensure of new vaccines, evaluating numerous vaccines throughout his career including vaccines for acellular pertussis, varicella, pneumococcal conjugate, human papillomavirus (HPV), influenza and shingles. He is currently the president and CEO of Biologics Consulting Group, Inc, where he is responsible for the overall management and strategic direction of the company. Prior to this, he spent 20 years at the U.S. Food and Drug Administration (FDA), most recently as Director of the Office of Vaccines Research and Review (OVRR) in the Center for Biologics Evaluation and Research (CBER). In this role, he oversaw all facets of the clinical and product regulatory review activity, including quality assurance and oversight of review functions in addition to planning, developing and administering CBER’s broad national and international programs and operational activities for vaccines and related products. Dr. Baylor served as FDA’s liaison to CDC’s Advisory Committee on Immunization Practices, the U.S. Department of Health and Human Services National Vaccine Advisory Committee, and the Advisory Commission on Childhood Vaccines. He served on the board of the Infectious Disease Research Institute and continues to serve as an expert advisor to the World Health Organization on several global vaccine initiatives. Dr. Baylor received his bachelor’s degree in medical microbiology from the University of Wisconsin, Madison, and his master’s degree and doctorate in microbial genetics and molecular microbiology, respectively, from the University of Kentucky. About JoAnn Suzich, PhDDr. JoAnn Suzich is an influential biotechnology leader with real-world experience translating science into global solutions for patient care with a focus on developing vaccines and antibodies against many of the deadly and debilitating viruses. Her work has played a critical role in the advancement and treatment of health issues affecting women and children. She currently serves as Head of Research at Immunocore after an impressive career at AstraZeneca/MedImmune where she started as a bench scientist and was elevated to Vice President and then Therapeutic Head before retiring in 2019. During her tenure as Vice President for Research & Development at MedImmune, she was responsible for research on novel vaccines, as well as overseeing the company’s research in the development of antibodies and antibody-like molecules for the prevention and treatment of infectious diseases including RSV, influenza, Staphylococcus aureus and Pseudomonas aeruginosa. As Research Director, Dr. Suzich managed the human papillomavirus (HPV) vaccine program from its inception to out-licensing following Phase 1 clinical trials.  She also serves as an advisor for organizations such as the Human Vaccines Project and the Global Women’s Health Institute at Purdue University. Dr. Suzich earned a doctorate in biochemistry from Purdue University and a bachelor’s degree in biology from Susquehanna University, where she now serves on the Board of Trustees.    CONTACT: Mary Beth Woodin Sabin Vaccine Institute +1 (202) 662-1841 press@sabin.org

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

News

Here’s how Helene and other storms dumped a whopping 40 trillion gallons of rain on the South

Published

 on

 

More than 40 trillion gallons of rain drenched the Southeast United States in the last week from Hurricane Helene and a run-of-the-mill rainstorm that sloshed in ahead of it — an unheard of amount of water that has stunned experts.

That’s enough to fill the Dallas Cowboys’ stadium 51,000 times, or Lake Tahoe just once. If it was concentrated just on the state of North Carolina that much water would be 3.5 feet deep (more than 1 meter). It’s enough to fill more than 60 million Olympic-size swimming pools.

“That’s an astronomical amount of precipitation,” said Ed Clark, head of the National Oceanic and Atmospheric Administration’s National Water Center in Tuscaloosa, Alabama. “I have not seen something in my 25 years of working at the weather service that is this geographically large of an extent and the sheer volume of water that fell from the sky.”

The flood damage from the rain is apocalyptic, meteorologists said. More than 100 people are dead, according to officials.

Private meteorologist Ryan Maue, a former NOAA chief scientist, calculated the amount of rain, using precipitation measurements made in 2.5-mile-by-2.5 mile grids as measured by satellites and ground observations. He came up with 40 trillion gallons through Sunday for the eastern United States, with 20 trillion gallons of that hitting just Georgia, Tennessee, the Carolinas and Florida from Hurricane Helene.

Clark did the calculations independently and said the 40 trillion gallon figure (151 trillion liters) is about right and, if anything, conservative. Maue said maybe 1 to 2 trillion more gallons of rain had fallen, much if it in Virginia, since his calculations.

Clark, who spends much of his work on issues of shrinking western water supplies, said to put the amount of rain in perspective, it’s more than twice the combined amount of water stored by two key Colorado River basin reservoirs: Lake Powell and Lake Mead.

Several meteorologists said this was a combination of two, maybe three storm systems. Before Helene struck, rain had fallen heavily for days because a low pressure system had “cut off” from the jet stream — which moves weather systems along west to east — and stalled over the Southeast. That funneled plenty of warm water from the Gulf of Mexico. And a storm that fell just short of named status parked along North Carolina’s Atlantic coast, dumping as much as 20 inches of rain, said North Carolina state climatologist Kathie Dello.

Then add Helene, one of the largest storms in the last couple decades and one that held plenty of rain because it was young and moved fast before it hit the Appalachians, said University of Albany hurricane expert Kristen Corbosiero.

“It was not just a perfect storm, but it was a combination of multiple storms that that led to the enormous amount of rain,” Maue said. “That collected at high elevation, we’re talking 3,000 to 6000 feet. And when you drop trillions of gallons on a mountain, that has to go down.”

The fact that these storms hit the mountains made everything worse, and not just because of runoff. The interaction between the mountains and the storm systems wrings more moisture out of the air, Clark, Maue and Corbosiero said.

North Carolina weather officials said their top measurement total was 31.33 inches in the tiny town of Busick. Mount Mitchell also got more than 2 feet of rainfall.

Before 2017’s Hurricane Harvey, “I said to our colleagues, you know, I never thought in my career that we would measure rainfall in feet,” Clark said. “And after Harvey, Florence, the more isolated events in eastern Kentucky, portions of South Dakota. We’re seeing events year in and year out where we are measuring rainfall in feet.”

Storms are getting wetter as the climate change s, said Corbosiero and Dello. A basic law of physics says the air holds nearly 4% more moisture for every degree Fahrenheit warmer (7% for every degree Celsius) and the world has warmed more than 2 degrees (1.2 degrees Celsius) since pre-industrial times.

Corbosiero said meteorologists are vigorously debating how much of Helene is due to worsening climate change and how much is random.

For Dello, the “fingerprints of climate change” were clear.

“We’ve seen tropical storm impacts in western North Carolina. But these storms are wetter and these storms are warmer. And there would have been a time when a tropical storm would have been heading toward North Carolina and would have caused some rain and some damage, but not apocalyptic destruction. ”

___

Follow AP’s climate coverage at https://apnews.com/hub/climate

___

Follow Seth Borenstein on Twitter at @borenbears

___

Associated Press climate and environmental coverage receives support from several private foundations. See more about AP’s climate initiative here. The AP is solely responsible for all content.

Source link

Continue Reading

Science

‘Big Sam’: Paleontologists unearth giant skull of Pachyrhinosaurus in Alberta

Published

 on

 

It’s a dinosaur that roamed Alberta’s badlands more than 70 million years ago, sporting a big, bumpy, bony head the size of a baby elephant.

On Wednesday, paleontologists near Grande Prairie pulled its 272-kilogram skull from the ground.

They call it “Big Sam.”

The adult Pachyrhinosaurus is the second plant-eating dinosaur to be unearthed from a dense bonebed belonging to a herd that died together on the edge of a valley that now sits 450 kilometres northwest of Edmonton.

It didn’t die alone.

“We have hundreds of juvenile bones in the bonebed, so we know that there are many babies and some adults among all of the big adults,” Emily Bamforth, a paleontologist with the nearby Philip J. Currie Dinosaur Museum, said in an interview on the way to the dig site.

She described the horned Pachyrhinosaurus as “the smaller, older cousin of the triceratops.”

“This species of dinosaur is endemic to the Grand Prairie area, so it’s found here and nowhere else in the world. They are … kind of about the size of an Indian elephant and a rhino,” she added.

The head alone, she said, is about the size of a baby elephant.

The discovery was a long time coming.

The bonebed was first discovered by a high school teacher out for a walk about 50 years ago. It took the teacher a decade to get anyone from southern Alberta to come to take a look.

“At the time, sort of in the ’70s and ’80s, paleontology in northern Alberta was virtually unknown,” said Bamforth.

When paleontogists eventually got to the site, Bamforth said, they learned “it’s actually one of the densest dinosaur bonebeds in North America.”

“It contains about 100 to 300 bones per square metre,” she said.

Paleontologists have been at the site sporadically ever since, combing through bones belonging to turtles, dinosaurs and lizards. Sixteen years ago, they discovered a large skull of an approximately 30-year-old Pachyrhinosaurus, which is now at the museum.

About a year ago, they found the second adult: Big Sam.

Bamforth said both dinosaurs are believed to have been the elders in the herd.

“Their distinguishing feature is that, instead of having a horn on their nose like a triceratops, they had this big, bony bump called a boss. And they have big, bony bumps over their eyes as well,” she said.

“It makes them look a little strange. It’s the one dinosaur that if you find it, it’s the only possible thing it can be.”

The genders of the two adults are unknown.

Bamforth said the extraction was difficult because Big Sam was intertwined in a cluster of about 300 other bones.

The skull was found upside down, “as if the animal was lying on its back,” but was well preserved, she said.

She said the excavation process involved putting plaster on the skull and wooden planks around if for stability. From there, it was lifted out — very carefully — with a crane, and was to be shipped on a trolley to the museum for study.

“I have extracted skulls in the past. This is probably the biggest one I’ve ever done though,” said Bamforth.

“It’s pretty exciting.”

This report by The Canadian Press was first published Sept. 25, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

The ancient jar smashed by a 4-year-old is back on display at an Israeli museum after repair

Published

 on

 

TEL AVIV, Israel (AP) — A rare Bronze-Era jar accidentally smashed by a 4-year-old visiting a museum was back on display Wednesday after restoration experts were able to carefully piece the artifact back together.

Last month, a family from northern Israel was visiting the museum when their youngest son tipped over the jar, which smashed into pieces.

Alex Geller, the boy’s father, said his son — the youngest of three — is exceptionally curious, and that the moment he heard the crash, “please let that not be my child” was the first thought that raced through his head.

The jar has been on display at the Hecht Museum in Haifa for 35 years. It was one of the only containers of its size and from that period still complete when it was discovered.

The Bronze Age jar is one of many artifacts exhibited out in the open, part of the Hecht Museum’s vision of letting visitors explore history without glass barriers, said Inbal Rivlin, the director of the museum, which is associated with Haifa University in northern Israel.

It was likely used to hold wine or oil, and dates back to between 2200 and 1500 B.C.

Rivlin and the museum decided to turn the moment, which captured international attention, into a teaching moment, inviting the Geller family back for a special visit and hands-on activity to illustrate the restoration process.

Rivlin added that the incident provided a welcome distraction from the ongoing war in Gaza. “Well, he’s just a kid. So I think that somehow it touches the heart of the people in Israel and around the world,“ said Rivlin.

Roee Shafir, a restoration expert at the museum, said the repairs would be fairly simple, as the pieces were from a single, complete jar. Archaeologists often face the more daunting task of sifting through piles of shards from multiple objects and trying to piece them together.

Experts used 3D technology, hi-resolution videos, and special glue to painstakingly reconstruct the large jar.

Less than two weeks after it broke, the jar went back on display at the museum. The gluing process left small hairline cracks, and a few pieces are missing, but the jar’s impressive size remains.

The only noticeable difference in the exhibit was a new sign reading “please don’t touch.”

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending